Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Apellis Pharmaceuticals Inc (APLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apellis Pharmaceuticals Inc 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 USA

P: 502-241-4114

Description:

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Apellis Pharmaceuticals, Inc. is based in CRESTWOOD, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,216,584
Shares Outstanding, K 63,232
Annual Sales, $ 0 K
Annual Net Income, $ -127,500 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,570 K
60-Month Beta 0.44
% of Insider Shareholders 9.30%
% of Institutional Shareholders 51.16%
Float, K 57,351
% Float 90.70%

Growth:

1-Year Return -4.48%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/13/19
Earnings Per Share ttm -2.77
EPS Growth vs. Prev Qtr -33.85%
EPS Growth vs. Prev Year -102.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

APLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -7.93
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -76.92
Return-on-Assets (Before Tax) -60.71
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.16
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.63
Book Value/Share 3.55
Interest Coverage -49.80
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar